Multiple Myeloma and Dexamethasone: Insights on Tapering, Dose Intensity, and Eye Health from New Research
Join us as Dr. Rahul Banerjee shares insightful information on managing dexamethasone in multiple myeloma patients. This session will cover key topics, including tapering dexamethasone and his latest research on how dose intensity and treatment outcomes. Additionally, we will share a way for you to participate in research through the ongoing Dexamethasone Eye Health Project in collaboration with HealthTree Cure Hub.
Cynthia introduces the agenda of the event and featured speaker Dr. Rahul Banerjee
Dr. Rahul Banerjee shares insightful information on managing dexamethasone in multiple myeloma patients
Type your questions in the chat and we will answer them!
Cynthia Cahoon, RN
Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.
Rahul Banerjee, MD, FACP
Dr. Banerjee’s clinical interests are in multiple myeloma, AL amyloidosis, and CAR-T therapy. His research interests are in toxicity management, digital health, and the patient experience.